The effect on relapse rate and psychiatric symptomatology: Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. A pragmatic randomized open-label trial (SwAP trial)
Mushde Shakir, Anne E. Willems, Peter N. van Harten, Remko van Lutterveld, Diederik E. Tenback
Topics & Concepts
PolypharmacyAntipsychoticBrief Psychiatric Rating ScaleSchizophrenia (object-oriented programming)ClozapinePsychiatryMedicineInternal medicinePsychosisPsychologySchizophrenia research and treatmentTreatment of Major DepressionHealthcare Decision-Making and Restraints